Breast Cancer Clinical Trials in Koto-ku, Tokyo
2 recruitingKoto-ku, Tokyo, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 3
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
Breast CancerAbemaciclibLocoregional Recurrence+1 more
Japanese Foundation for Cancer Research290 enrolled1 locationNCT07190443